Compound HRAS/PIK3CA Mutations in Chinese Patients with Alveolar Rhabdomyosarcomas |
Liu, Chun-Xia
(Department of Pathology, Shihezi University School of Medicine)
Li, Xiao-Ying (Department of Pathology, Shihezi University School of Medicine) Li, Cheng-Fang (Department of Pathology, Shihezi University School of Medicine) Chen, Yun-Zhao (Department of Pathology, Shihezi University School of Medicine) Cui, Xiao-Bin (Department of Pathology, Shihezi University School of Medicine) Hu, Jian-Ming (Department of Pathology, Shihezi University School of Medicine) Li, Feng (Department of Pathology, Shihezi University School of Medicine) |
1 | Taylor JG, Cheuk AT, Tsang PS, et al (2009). Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest, 119, 3395-407. |
2 | Thomas RK, Baker AC, Debiasi RM, et al (2007). Highthroughput oncogene mutation profiling in human cancer. Nat Genet, 39, 347-51. DOI ScienceOn |
3 | Kratz CP, Steinemann D, Niemeyer CM, et al (2007). Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome, Hum Mol Genet, 16, 374-9. DOI |
4 | Anderson J, Gordon A, Pritchard-Jones K, et al (1999). Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer, 26, 275-85. DOI |
5 | De Giovanni C, Landuzzi L, Nicoletti G, et al (2009). Molecular and cellular biology of rhabdomyosarcoma. Future Oncol, 5, 1449-75. DOI |
6 | Langenau DM, Keefe MD, Storer NY, et al (2007). Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev, 21, 1382-95. DOI |
7 | Martinelli S, McDowell HP, Vigne SD, et al (2009). RAS signaling dysregulation in human embryonal Rhabdomyosarcoma. Genes Chromosomes Cancer, 48, 975-82. DOI |
8 | Paulson V, Chandler G, Rakheja D, et al (2011). Highresolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis. Genes Chromosomes Cancer, 50, 397-408. DOI |
9 | Shukla N, Ameur N, Yilmaz I, et al (2012). Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Clin Cancer Res, 18, 748-57. DOI |
10 | Xin G, Dong-Sheng H, Ji-Tong Sh, et al (2013). Multidisciplinary collaborative therapy for 30 children with orbital rhabdomyosarcoma. Asian Pac J Cancer Prev, 14, 4641-6. DOI |
11 | Stratton MR, Fisher C, Gusterson BA, et al (1989). Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res, 49, 6324-7. |
12 | Sorensen PH, Lynch JC, Qualman SJ, et al (2002). PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group. J Clin Oncol, 20, 2672-9. DOI |
13 | Chen Y, Takita J, Hiwatari M, et al (2006). Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies. Genes Chromosomes Cancer, 45, 583-91. DOI |